FDA advisers endorse bivalent vaccine for all COVID mRNA shots
By
Alicia Lasek
Jan 27, 2023
A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, phasing out the original vaccines.
Post-op delirium tied to faster cognitive decline in 6-year study
By
Alicia Lasek
Mar 22, 2023
Postoperative delirium may speed the rate of cognitive decline in older adults by 40% within six years after a major elective surgery, a new study has found
Seven-month study supports benefits of COVID-19 antivirals in seniors
By
Alicia Lasek
Dec 15, 2022
With monoclonal antibodies no longer effective against newer strains of SARS-CoV-2, the findings support prescribing the antiviral pill Paxlovid to eligible patients, doctors say.
Fall vaccination campaign could avert 160,000 U.S. deaths, analysts project
By
Alicia Lasek (f3)
Jul 27, 2022
Fully 160,000 deaths and 1.7 million hospitalizations could be averted if 80% of the eligible U.S. population received COVID-19 booster doses this fall, the Commonwealth Fund estimates in a new report.
Medicare eligibility comes with increase in tooth loss, Harvard study reveals
By
Alicia Lasek
Feb 10, 2023
When patients become eligible for Medicare coverage, restorative dental care immediately falls and tooth loss increases, a new study from Harvard University and Brigham and Women’s Hospital has found.
Peer messaging tool tackles workplace behavior, shows success in nurse study
By
Alicia Lasek
Jan 06, 2023
The CORS tool allows behavior to be anonymously reported and addressed by a trained peer, without involving nursing leadership or human resources unless necessary.
Hurricanes hastened the deaths of adults with dementia, study finds
By
Alicia Lasek
Mar 08, 2023
People with Alzheimer’s and related dementias (ADRD) had higher mortality rates in U.S. counties that had recently experienced a hurricane disaster, investigators report.
Monoclonal antibodies ‘unequivocally’ saved lives during pandemic, patient data show
By
Alicia Lasek
Apr 14, 2023
For two years, monoclonal antibodies were approved, revoked and sometimes reauthorized or scarce, but pushing through these challenges “unequivocally saved lives and prevented hospitalizations,”...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.